Analysis of the trends of polypharmacy and high‐dose prescriptions in Japan

After extensive research, this study explored whether high‐dose prescriptions and polypharmacy remain more frequent in Japan than elsewhere. If confirmed, we aimed to identify the factors that contributed to this unique trend.

[1]  K. Sim,et al.  Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: Findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey. , 2019, Asian journal of psychiatry.

[2]  K. Sim,et al.  Antipsychotic Polypharmacy in Older Adult Asian Patients With Schizophrenia: Research on Asian Psychotropic Prescription Pattern , 2019, Journal of geriatric psychiatry and neurology.

[3]  Yoichi Ii,et al.  Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database , 2019, Clinical Drug Investigation.

[4]  S. Kanba,et al.  Concurrent antipsychotic use in older adults treated with antidepressants in Asia , 2019, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[5]  K. Sim,et al.  Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics , 2018, Psychiatry and clinical neurosciences.

[6]  Takahiro A. Kato,et al.  Comparison of the Defined Daily Dose and Chlorpromazine Equivalent Methods in Antipsychotic Drug Utilization in Six Asian Countries , 2018 .

[7]  Takahiro A. Kato,et al.  Comparison of treatment patterns in schizophrenia between China and Japan (2001‐2009) , 2017, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

[8]  N. Shinfuku.  Mental Health System in Japan After the Meiji Restoration: Historical Observations , 2017 .

[9]  T. Si,et al.  QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009 , 2015, Human psychopharmacology.

[10]  M. Pérez-Nieto,et al.  Thirty years of scientific research on second-generation antipsychotic drugs in Japan: A bibliometric analysis , 2013 .

[11]  F. Dickerson,et al.  Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009). , 2012, Journal of clinical psychopharmacology.

[12]  T. Higuchi,et al.  International variation in antipsychotic prescribing for schizophrenia: Pooled results from the research on East Asia psychotropic prescription (reap) studies , 2012 .

[13]  F. Dickerson,et al.  Use of first- and second-generation antipsychotic medications in older patients with schizophrenia in Asia (2001–2009) , 2012, The Australian and New Zealand journal of psychiatry.

[14]  C. Correll,et al.  Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009 , 2012, Schizophrenia Research.

[15]  F. Dickerson,et al.  Antipsychotic treatment in older schizophrenia patients with extrapyramidal side effects in Asia (2001 - 2009). , 2012, International journal of clinical pharmacology and therapeutics.

[16]  F. Dickerson,et al.  Adjunctive Mood Stabilizer and Benzodiazepine Use in Older Asian Patients with Schizophrenia, 2001–2009 , 2012, Pharmacopsychiatry.

[17]  T. Si,et al.  Antipsychotic Polypharmacy in Inpatients with Schizophrenia in Asia (2001−2009) , 2011, Pharmacopsychiatry.

[18]  R. Baldessarini,et al.  Adjunctive mood stabilizer treatment for hospitalized schizophrenia patients: Asia psychotropic prescription study (2001-2008). , 2011, The international journal of neuropsychopharmacology.

[19]  T. Si,et al.  The low frequency of reported sexual dysfunction in Asian patients with schizophrenia (2001–2009): low occurrence or ignored side effect? , 2011, Human psychopharmacology.

[20]  T. Si,et al.  Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009. , 2011, Pharmacopsychiatry.

[21]  K. Sim,et al.  Psychotropic prescription practices in east Asia: looking back and peering ahead , 2008, Current opinion in psychiatry.

[22]  N. Shinfuku,et al.  Pharmacotherapy for schizophrenic inpatients in East Asia – Changes and challenges , 2008, International review of psychiatry.

[23]  R. Yoshimura,et al.  Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: Research on East Asia Psychotropic Prescription Pattern–Antipsychotics study , 2006, Psychiatry and clinical neurosciences.

[24]  T. Higuchi,et al.  Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription. , 2005, The British journal of psychiatry : the journal of mental science.

[25]  S. Heckers,et al.  Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. , 2004, British journal of clinical pharmacology.

[26]  T. Si,et al.  Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change , 2004, Psychiatry and clinical neurosciences.

[27]  N. Shinfuku.  Mental health services in Asia: International perspective and challenge for the coming years , 1998, Psychiatry and clinical neurosciences.